September 29, 2023 by Jason Wertheimer Endpoints News Exclusive: Former Genentech duo reunites to push Sonoma into the clinic Learn More
May 13, 2023 by Jason Wertheimer Sonoma Bio Sonoma Biotherapeutics Presents Data on Engineered Treg Cell Therapies Equipped with IL-2 Signaling at IMMUNOLOGY2023™ Learn More
March 28, 2023 by Jason Wertheimer Fierce Biotech Sonoma takes ‘a big bite’ with $120M Regeneron Treg collab, tacking on up to 5 new targets Learn More
March 28, 2023 by Jason Wertheimer GeekWire Sonoma Bio inks $75M deal with Regeneron to advance cell therapies against autoimmunity Learn More
March 28, 2023 by Jason Wertheimer Endpoints News Jeffrey Bluestone brings his startup haul to $400M+, joining forces with Regeneron on cell therapies Learn More
August 24, 2022 by Jason Wertheimer Endpoints News Sonoma Bio to cement its roots in Seattle with a new waterfront manufacturing and R&D site Learn More